India via BEL: What Is Actually Firm in Reshef's Multi-Year Framework and What Still Depends on Local Production
The BEL framework sounds like an opportunity worth up to about $200 million, but the hard layer today is much narrower: the operational order and letters of credit for the first two years total about $39 million. The next layer of value already depends on local production in India, licensing, and on how much manufacturing economics Reshef can still keep for itself.
The main article argued that Arit's 2026 outcome will be decided less by the size of its cash pile and more by the quality of the new backlog coming from India, Europe, and the U.S. This follow-up isolates India through BEL, because this is where the gap between the headline and the real economics is especially wide.
This is the core point: the roughly $200 million associated with the India multi-year framework is not the same thing as $200 million of hard economics already sitting in the book. The hard layer today is the operational order and letters of credit for the first two years, roughly $39 million. Above that sits a broader contractual layer, and above that another layer that depends on local production in India, licensing, and on timely execution.
This is not a semantic distinction. It is an economic one. When the market hears "10-year agreement," it tends to hear duration, certainty, and visibility. But here the quality of each dollar matters as much as the quantity: which part is already backed by operational orders, which part still depends on deciding the local-production route, and which part may only arrive if Reshef chooses a structure that still leaves enough value in its own hands.
What Is Already Firm
Reshef and BEL have been working together since 2015. The original commercial agreement was signed in December 2015 for 15 years, under which Reshef committed to help establish an electronic-fuze assembly plant in India and provide technical support for production and assembly. That matters because India was never built as a pure Israeli export model. It was built as a workshare model from the outset.
In December 2024, the parties signed the order agreement that implements BEL's multi-year contract with the Indian Army. That is the basis for the big headline. But the company itself breaks the economics into three distinct layers, and they do not carry the same degree of certainty.
| Layer | Amount | What exists today | What is still missing |
|---|---|---|---|
| Operational order for years 1 to 2 | About $39 million | Operational order and letters of credit have already been received from BEL | Execution and delivery |
| Regular framework layer | About $141 million over 10 years | Includes the first two years and the portion expected to remain with Reshef in years 3 to 10 | Operational orders and letters of credit for years 3 to 10 will be issued only later |
| Local-production layer | About $58 million additional | Not firm, contingent on meeting local-production requirements and completing the required actions on time | Local manufacturing capability, permits, and the chosen structural route |
This chart is the heart of the distinction. The first $39 million is not just smaller than the headline. It is also the only portion the company explicitly says is already backed by both an operational order and letters of credit, and the only portion that is not exposed, at the report approval date, to rupee-dollar FX changes. By year-end 2025, Reshef had already supplied about NIS 41 million from that layer.
By contrast, the rest of the regular framework layer has not yet fully reached the level of operational ordering. The company explicitly says that the operational order and letters of credit for years 3 to 10 will be transferred only in the future, and only after the start date of local production in India and the chosen production route are determined. In other words, even within the $141 million layer, not every dollar carries the same level of firmness.
Where Local Production Starts to Change the Economics
This is where the reading can easily go wrong. Under the terms of BEL's multi-year contract, starting in year 3, certain component details that Reshef currently manufactures fully in Israel are supposed to be produced in India. The start of local production can be delayed to year 4 or year 5, but that delay is not free: it is subject to a performance guarantee of about $2.5 million per year, up to a total of $5 million.
There is also a downside embedded in that delay. BEL is supposed to provide the performance guarantee to the Indian Army, and if the parties ultimately fail to meet the local-production conditions by year 5, Reshef is supposed to indemnify BEL for about 37% of the amount actually forfeited. So local production is not only an upside trigger. It is also a friction point with a potential economic cost.
The more important issue is the structure of the available routes. Reshef can satisfy the local-production requirement in one of three ways:
- Through an Indian subsidiary owned by Reshef.
- Through a joint venture with BEL in which Reshef holds more than 50%.
- Through an additional know-how transfer agreement to BEL, under which BEL would manufacture the relevant components in India itself.
That is not only an operational question. It is a value-capture question. The company makes clear that the additional roughly $58 million is based on the first route, meaning production in India by a Reshef subsidiary. If route 2 or route 3 is ultimately chosen, the company estimates the additional amount would be lower. Put plainly, even if India advances broadly as planned, the full incremental economics the market imagines may not remain with Reshef.
There is an even more precise point underneath that. Based on the legal opinion Reshef received, the local-production requirement applies to 50.01% of the value of each relevant component separately, and it applies to two out of the three components that Reshef is supposed to supply to BEL. In total, this comes to about 36% of the value of the components Reshef is supposed to supply under the order agreement. That is important because it means the fight is not over the entire economics of the contract. It is over a defined slice of it. But that slice is exactly where the incremental value layer sits.
The second chart sharpens another point the market can easily miss: delaying local production does not necessarily destroy the economics, but it does change their mix. If local production starts only in year 5, the regular framework layer rises to about $155 million, while the contingent local-production layer falls to about $44.5 million. So the real question is not just whether India happens. It is how quickly it happens, through which structure, and where the value sits along the way.
What the Headline Hides About Revenue Quality
The up-to-$200-million number describes a framework ceiling. It is not the same as hard backlog, and it is not the same as what is already visible in 2025 revenue. At year-end 2025, the company separately presents about $131 million from the regular leg of the agreement and a contingent order of about $52.5 million. Within that $131 million, the company had already received an operational order for about $39 million for the first two years, while the operational order for years 3 to 10 is supposed to come only later and subject to the agreement conditions.
That is why India still looks smaller in the income statement than it does in the headline narrative. In 2025, sales to India amounted to about NIS 44.9 million, and BEL accounted for 9% of group revenue. That is meaningful, but it is still far from the feeling created by an "up to $200 million" headline. The gap is not necessarily a weakness. It simply means the story is still in the conversion phase from framework to shipments.
Another point worth keeping in mind is that the India model never started from a promise that all manufacturing economics would remain with Reshef. Under the 2015 framework itself, BEL was allowed to buy from third parties or manufacture on its own all fuze components except for one critical component that Reshef would supply, plus any additional components Reshef might choose to retain if it exercised the option granted to it. So the debate around local production is not a new event that suddenly damages a clean export contract. It is part of the structure that was there from day one.
The battery development sits exactly on that fault line. The company successfully developed an Israeli-made battery, a critical component that is in short supply in the global market. It has already started producing the batteries for internal use inside the fuzes it delivers, and the company says the product also has separate sales potential, including under BEL's multi-year framework. But separate battery sales have not started yet, and the company expects them only in 2027. So here too, the right reading is optional upside, not hard economics for 2025 or early 2026.
The post-balance-sheet update follows the same pattern. In March 2026, BEL informed Reshef that it had won another Indian Ministry of Defence tender, and Reshef's expected share was presented at about $4.4 million. But the company itself says Reshef's final share will only be determined once the supply agreement is completed, if it is completed at all. So even the latest positive India news still arrives in the form of an opportunity pipeline rather than firm, countable economics.
Conclusions
India via BEL is a real opportunity, but the hard economics are narrower than the headline. What is locked in today is mostly the first-two-year layer, backed by an operational order and letters of credit. What comes after that runs through a more complicated question: how much manufacturing shifts to India, through which structure, and at what point in the chain Reshef still keeps the value for itself.
That also determines the correct reading of revenue quality. If local production is executed through a Reshef subsidiary, and if the permits and setup progress on time, a meaningful extra layer of value can emerge. If the route ends up being a joint venture or an additional know-how transfer to BEL, the incremental economics will be smaller. And if there is delay, the timing of years 3 to 10 ordering will remain more open as well.
So the right investor question is not whether India is real. It is. The right question is how much of India has already become letter-of-credit-backed work, how much still rests on the choice of local-production model, and how much of the future value will stay with Reshef rather than moving to BEL or to a local-production structure that dilutes Reshef's share of the economics.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.